How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans
CELforPharma
How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans
2:07
What does business acumen for MSLs mean?
CELforPharma
What does business acumen for MSLs mean?
0:58
The 6 principles of good pharma forecasting by Gary Johnson, CELforPharma faculty member
CELforPharma
The 6 principles of good pharma forecasting by Gary Johnson, CELforPharma faculty member
2:03
The Pharma Licensing Process Overview - a Presentation by David Scott
CELforPharma
The Pharma Licensing Process Overview - a Presentation by David Scott
4:33
What are the different types of payers? by Gary Johnson, CELforPharma faculty member
CELforPharma
What are the different types of payers? by Gary Johnson, CELforPharma faculty member
2:13
10 Critical Success Factors for Pharma Lifecycle Management
CELforPharma
10 Critical Success Factors for Pharma Lifecycle Management
7:53
What is a QALY and how to calculate it? B Prof. Dr. Lieven Annemans, CELforPharma faculty member
CELforPharma
What is a QALY and how to calculate it? B Prof. Dr. Lieven Annemans, CELforPharma faculty member
2:25
What is AI & Machine Learning and why compare it to Econometrics/Extrapolation in pharma forecasting
CELforPharma
What is AI & Machine Learning and why compare it to Econometrics/Extrapolation in pharma forecasting
1:41
9.5 steps to a successful Advisory Board Meeting
CELforPharma
9.5 steps to a successful Advisory Board Meeting
1:37
Health Economic Evaluations and Health Technology Assessments
CELforPharma
Health Economic Evaluations and Health Technology Assessments
0:34
Introduction "Health Economics for Non-Health-Economists" by Prof. Dr. Lieven Annemans
CELforPharma
Introduction "Health Economics for Non-Health-Economists" by Prof. Dr. Lieven Annemans
2:17
PBP challenges
CELforPharma
PBP challenges
1:47